In addition, the literature retrieval time of the latest meta-analysis was up to November 2020 [30], not to mention the unfavorable quality of evidence, the absence of GRADE evaluation, and the unconfirmed prioritization of EGFR-TKIs with or without RT for BMs of NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.